Back
Sage Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
SAGE
Sage Therapeutics
Last Price:
$6.90
Seasonality Move:
-1.48%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.67 | Buy |
20-day SMA: | 7.16 | Sell |
50-day SMA: | 7.46 | Sell |
200-day SMA: | 7.12 | Sell |
8-day EMA: | 6.75 | Buy |
20-day EMA: | 7 | Sell |
50-day EMA: | 7.2 | Sell |
200-day EMA: | 8.61 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 45.69 | Sell |
Chaikin Money Flow: | 579958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.77 - 7.63) | Sell |
Bollinger Bands (100): | (6.33 - 7.87) | Sell |
Sage Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.89 while SAGE 8-day simple moving average is 6.67, which is a Buy signal.
-
The stock price of SAGE is 6.89 while Sage Therapeutics 20-day SMA is 7.16, which makes it a Sell.
-
Sage Therapeutics 50-day simple moving average is 7.46 while SAGE share price is 6.89, making it a Sell technically.
-
SAGE stock price is 6.89 and Sage Therapeutics 200-day simple moving average is 7.12, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
20
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $6.89. The Score for SAGE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
431.5M
Price in USD:
6.89
Share Volume:
734.6K
Sage Therapeutics 52-Week Range
52-Week High:
13.47
52-Week Low:
4.62
Sell
20
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 6.89 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.89 while SAGE 8-day exponential moving average is 6.75, which is a Buy signal.
-
The stock price of SAGE is 6.89 while Sage Therapeutics 20-day EMA is 7.00, which makes it a Sell.
-
Sage Therapeutics 50-day exponential moving average is 7.20 while SAGE share price is 6.89, making it a Sell technically.
-
SAGE stock price is 6.89 and Sage Therapeutics 200-day simple moving average is 8.61, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.40 per share, an increase this year of $2.81 per share, and an increase next year of $0.36 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Sage Therapeutics is a Sell
-
Sage Therapeutics Relative Strength Index (RSI) is 45.69, which suggest Sage Therapeutics is oversold
-
The Bollinger Bands (25) for Sage Therapeutics is (6.77 - 7.63), which suggest Sage Therapeutics is a Sell
-
The Bollinger Bands (100) for Sage Therapeutics is (6.33 - 7.87), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.